BRAF and cardiac hypertrophy: As in previous studies [29], phenylephrine promoted cardiac hypertrophy as assessed by echocardiography with decreased LV internal diameter and increased wall thickness, and neither appeared to be significantly affected in hearts of mice with cardiomyocyte BRAF knockout (Figure 5A; Supplementary Table S6).